Nicole Vitullo Domain Associates “In the Spotlight” w/ Celator’s “Cinderella story” happily ending in $1.5B sale to Jazz @ womenspebriefs.com

.Gavin Stone: We're taking a multidisciplinary approach to a problem that hadn't been optimized previously: big data in genomics #BIO2016

.Gavin Stone: Genomics poised to be the biggest of all #bigdata areas, soon to overshadow Twitter #BIO2016

.Gavin Stone: Imagine taking 800 phone books, shredding them, and then reassembling so they make sentences. This is sequencing. #Bio2016

Thank you! Honored to be a part of today's events.#BIO2016 x.com/permedcoalitio…

Listen to our discussion on #genomics at #BIO2016 w/ Genome Alberta Edico Genome @bionanogenomics Indi (Integrated Dx) - bit.ly/1XaSxxa

More to come at #BIO2016! Join us as Biocon, Knight Therapeutics & DRI discuss building #biotech in complex markets 10:30a North 123

Want to learn about biotech in complex markets? Didn't miss the panel happening in north 123 right now #BIO2016

Question of the day - What does it take to particiate effectively in complex or non-established markets? #BIO2016

Partnership with Russian government was key to building NovaMedica #BIO2016

Jonathan Goodman - #Canada has 10 different markets, multiple languages and complex regulation that requires expert navigation #BIO2016

.The Wharton School's Stephen Sammut - most would be surprised to learn that Sub-Saharan Africa is place for innovation in the life sciences #BIO2016

.Biocon CEO - we are a global company that happens to be based in India #BIO2016

Jonathan Goodman's vision for Knight Therapeutics is to be a one stop shop for rest of world market #BIO2016

Marinus Pharmaceuticals Doses First Subject in Phase 1 Clinical Trial for Ganaxolone IV tinyurl.com/jrzzuns

.@Allergan to buy Domain Associates & Frazier Healthcare Partners backed Tobira Therapeutics in $1.7 B deal hubs.ly/H04r9Yz0

Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH tinyurl.com/jxowz2c

MARINUS ANNOUNCES POSITIVE PRELIMINARY DATA FROM CHILDREN WITH CDKL5 GENETIC DISORDER tinyurl.com/hjcudxs

Esperion Completes Enrollment of Pivotal Phase 3 Study of Bempedoic Acid in Patients with Hypercholesterolemia tinyurl.com/jxbmee7

ChromaCode Raises $12 Million in Series B for Commercial Launch and Appoints Alex Dickinson as Executive Chair tinyurl.com/nxkfd9f